Table of Content
?TABLE OF CONTENTS
1 Research Methodology and Statistical Scope 1
1.1 Market Definition and Statistical Scope of Biologics and Biosimilars 1
1.2 Key Market Segments 1
1.2.1 Biologics and Biosimilars Segment by Type 1
1.2.2 Biologics and Biosimilars Segment by Application 2
1.3 Methodology & Sources of Information 3
1.3.1 Research Methodology 3
1.3.2 Research Process 4
1.3.3 Market Breakdown and Data Triangulation 5
1.3.4 Base Year 5
1.3.5 Report Assumptions & Caveats 6
2 Biologics and Biosimilars Market Overview 8
2.1 Global Market Overview 8
2.1.1 Global Biologics and Biosimilars Market Size (M USD) Estimates and Forecasts (2017-2028) 8
2.1.2 Global Biologics and Biosimilars Sales Estimates and Forecasts (2017-2028) 9
2.2 Market Segment Executive Summary 9
2.3 Global Market Size by Region 11
3 Biologics and Biosimilars Market Competitive Landscape 13
3.1 Global Biologics and Biosimilars Sales by Manufacturers (2017-2022) 13
3.2 Global Biologics and Biosimilars Revenue Market Share by Manufacturers (2017-2022) 15
3.3 Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 16
3.4 Global Biologics and Biosimilars Average Price by Manufacturers (2017-2022) 17
3.5 Manufacturers Biologics and Biosimilars Sales Sites, Area Served, Product Type 18
3.6 Biologics and Biosimilars Market Competitive Situation and Trends 19
3.6.1 Biologics and Biosimilars Market Concentration Rate 19
3.6.2 Global 5 and 10 Largest Biologics and Biosimilars Players Market Share by Revenue 21
3.6.3 Mergers & Acquisitions, Expansion 21
4 Biologics and Biosimilars Industry Chain Analysis 22
4.1 Biologics and Biosimilars Industry Chain Analysis 22
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 22
4.3 Midstream Market Analysis 23
4.4 Downstream Customer Analysis 23
5 The Development and Dynamics of Biologics and Biosimilars Market 25
5.1 Key Development Trends 25
5.2 Driving Factors 25
5.3 Market Challenges 25
5.4 Market Restraints 26
5.5 Industry News 26
5.5.1 New Product Developments 26
5.5.2 Mergers & Acquisitions 26
5.5.3 Expansions 26
5.5.4 Collaboration/Supply Contracts 26
5.6 Industry Policies 26
6 Biologics and Biosimilars Market Segmentation by Type 27
6.1 Evaluation Matrix of Segment Market Development Potential (Type) 27
6.2 Global Biologics and Biosimilars Sales Market Share by Type (2017-2022) 28
6.3 Global Biologics and Biosimilars Market Size Market Share by Type (2017-2022) 29
6.4 Global Biologics and Biosimilars Price by Type (2017-2022) 30
7 Biologics and Biosimilars Market Segmentation by Application 31
7.1 Evaluation Matrix of Segment Market Development Potential (Application) 31
7.2 Global Biologics and Biosimilars Market Sales by Application (2017-2022) 32
7.3 Global Biologics and Biosimilars Market Size (M USD) by Application (2017-2022) 33
7.4 Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022) 34
8 Biologics and Biosimilars Market Segmentation by Region 35
8.1 Global Biologics and Biosimilars Sales by Region 35
8.1.1 Global Biologics and Biosimilars Sales by Region 35
8.1.2 Global Biologics and Biosimilars Sales Market Share by Region 35
8.2 North America 36
8.2.1 North America Biologics and Biosimilars Sales by Country 36
8.2.2 U.S. 37
8.2.3 Canada 37
8.2.4 Mexico 37
8.3 Europe 37
8.3.1 Europe Biologics and Biosimilars Sales by Country 38
8.3.2 Germany 38
8.3.3 France 38
8.3.4 U.K. 38
8.3.5 Italy 39
8.3.6 Russia 39
8.4 Asia Pacific 39
8.4.1 Asia Pacific Biologics and Biosimilars Sales by Region 39
8.4.2 China 40
8.4.3 Japan 40
8.4.4 South Korea 40
8.4.5 India 40
8.4.6 Southeast Asia 40
8.5 South America 40
8.5.1 South America Biologics and Biosimilars Sales by Country 41
8.5.2 Brazil 41
8.5.3 Argentina 41
8.5.4 Columbia 41
8.6 Middle East and Africa 41
8.6.1 Middle East and Africa Biologics and Biosimilars Sales by Region 42
8.6.2 Saudi Arabia 42
8.6.3 UAE 42
8.6.4 Egypt 42
8.6.5 Nigeria 43
8.6.6 South Africa 43
9 Key Companies Profiled 44
9.1 Roche 44
9.1.1 Roche Biologics and Biosimilars Basic Information 44
9.1.2 Roche Biologics and Biosimilars Product Overview 44
9.1.3 Roche Biologics and Biosimilars Product Market Performance 44
9.1.4 Roche Business Overview 45
9.1.5 Roche Biologics and Biosimilars SWOT Analysis 45
9.1.6 Roche Recent Developments 45
9.2 Amgen 46
9.2.1 Amgen Biologics and Biosimilars Basic Information 46
9.2.2 Amgen Biologics and Biosimilars Product Overview 46
9.2.3 Amgen Biologics and Biosimilars Product Market Performance 46
9.2.4 Amgen Business Overview 47
9.2.5 Amgen Biologics and Biosimilars SWOT Analysis 47
9.2.6 Amgen Recent Developments 47
9.3 AbbVie 47
9.3.1 AbbVie Biologics and Biosimilars Basic Information 47
9.3.2 AbbVie Biologics and Biosimilars Product Overview 48
9.3.3 AbbVie Biologics and Biosimilars Product Market Performance 48
9.3.4 AbbVie Business Overview 48
9.3.5 AbbVie Biologics and Biosimilars SWOT Analysis 49
9.3.6 AbbVie Recent Developments 49
9.4 Sanofi-Aventis 49
9.4.1 Sanofi-Aventis Biologics and Biosimilars Basic Information 49
9.4.2 Sanofi-Aventis Biologics and Biosimilars Product Overview 50
9.4.3 Sanofi-Aventis Biologics and Biosimilars Product Market Performance 50
9.4.4 Sanofi-Aventis Business Overview 50
9.4.5 Sanofi-Aventis Biologics and Biosimilars SWOT Analysis 50
9.4.6 Sanofi-Aventis Recent Developments 51
9.5 Johnson & Johnson 51
9.5.1 Johnson & Johnson Biologics and Biosimilars Basic Information 51
9.5.2 Johnson & Johnson Biologics and Biosimilars Product Overview 51
9.5.3 Johnson & Johnson Biologics and Biosimilars Product Market Performance 52
9.5.4 Johnson & Johnson Business Overview 52
9.5.5 Johnson & Johnson Biologics and Biosimilars SWOT Analysis 52
9.5.6 Johnson & Johnson Recent Developments 52
9.6 Pfizer 53
9.6.1 Pfizer Biologics and Biosimilars Basic Information 53
9.6.2 Pfizer Biologics and Biosimilars Product Overview 53
9.6.3 Pfizer Biologics and Biosimilars Product Market Performance 53
9.6.4 Pfizer Business Overview 54
9.6.5 Pfizer Recent Developments 54
9.7 Novo Nordisk 54
9.7.1 Novo Nordisk Biologics and Biosimilars Basic Information 54
9.7.2 Novo Nordisk Biologics and Biosimilars Product Overview 55
9.7.3 Novo Nordisk Biologics and Biosimilars Product Market Performance 55
9.7.4 Novo Nordisk Business Overview 55
9.7.5 Novo Nordisk Recent Developments 55
9.8 Eli Lilly 56
9.8.1 Eli Lilly Biologics and Biosimilars Basic Information 56
9.8.2 Eli Lilly Biologics and Biosimilars Product Overview 56
9.8.3 Eli Lilly Biologics and Biosimilars Product Market Performance 56
9.8.4 Eli Lilly Business Overview 57
9.8.5 Eli Lilly Recent Developments 57
9.9 Novartis 57
9.9.1 Novartis Biologics and Biosimilars Basic Information 57
9.9.2 Novartis Biologics and Biosimilars Product Overview 58
9.9.3 Novartis Biologics and Biosimilars Product Market Performance 58
9.9.4 Novartis Business Overview 58
9.9.5 Novartis Recent Developments 58
9.10 Merck 59
9.10.1 Merck Biologics and Biosimilars Basic Information 59
9.10.2 Merck Biologics and Biosimilars Product Overview 59
9.10.3 Merck Biologics and Biosimilars Product Market Performance 59
9.10.4 Merck Business Overview 60
9.10.5 Merck Recent Developments 60
9.11 3sbio 60
9.11.1 3sbio Biologics and Biosimilars Basic Information 60
9.11.2 3sbio Biologics and Biosimilars Product Overview 61
9.11.3 3sbio Biologics and Biosimilars Product Market Performance 61
9.11.4 3sbio Business Overview 61
9.11.5 3sbio Recent Developments 61
9.12 Changchun High Tech 62
9.12.1 Changchun High Tech Biologics and Biosimilars Basic Information 62
9.12.2 Changchun High Tech Biologics and Biosimilars Product Overview 62
9.12.3 Changchun High Tech Biologics and Biosimilars Product Market Performance 62
9.12.4 Changchun High Tech Business Overview 63
9.12.5 Changchun High Tech Recent Developments 63
9.13 CP Guojian 63
9.13.1 CP Guojian Biologics and Biosimilars Basic Information 63
9.13.2 CP Guojian Biologics and Biosimilars Product Overview 64
9.13.3 CP Guojian Biologics and Biosimilars Product Market Performance 64
9.13.4 CP Guojian Business Overview 64
9.13.5 CP Guojian Recent Developments 64
9.14 Biotech 65
9.14.1 Biotech Biologics and Biosimilars Basic Information 65
9.14.2 Biotech Biologics and Biosimilars Product Overview 65
9.14.3 Biotech Biologics and Biosimilars Product Market Performance 65
9.14.4 Biotech Business Overview 66
9.14.5 Biotech Recent Developments 66
9.15 Gelgen 66
9.15.1 Gelgen Biologics and Biosimilars Basic Information 66
9.15.2 Gelgen Biologics and Biosimilars Product Overview 67
9.15.3 Gelgen Biologics and Biosimilars Product Market Performance 67
9.15.4 Gelgen Business Overview 67
9.15.5 Gelgen Recent Developments 67
9.16 Innovent 68
9.16.1 Innovent Biologics and Biosimilars Basic Information 68
9.16.2 Innovent Biologics and Biosimilars Product Overview 68
9.16.3 Innovent Biologics and Biosimilars Product Market Performance 68
9.16.4 Innovent Business Overview 69
9.16.5 Innovent Recent Developments 69
9.17 Dong Bao 69
9.17.1 Dong Bao Biologics and Biosimilars Basic Information 69
9.17.2 Dong Bao Biologics and Biosimilars Product Overview 70
9.17.3 Dong Bao Biologics and Biosimilars Product Market Performance 70
9.17.4 Dong Bao Business Overview 70
9.17.5 Dong Bao Recent Developments 70
9.18 Ganlee 71
9.18.1 Ganlee Biologics and Biosimilars Basic Information 71
9.18.2 Ganlee Biologics and Biosimilars Product Overview 71
9.18.3 Ganlee Biologics and Biosimilars Product Market Performance 71
9.18.4 Ganlee Business Overview 72
9.18.5 Ganlee Recent Developments 72
9.19 United Laboratories 72
9.19.1 United Laboratories Biologics and Biosimilars Basic Information 72
9.19.2 United Laboratories Biologics and Biosimilars Product Overview 73
9.19.3 United Laboratories Biologics and Biosimilars Product Market Performance 73
9.19.4 United Laboratories Business Overview 73
9.19.5 United Laboratories Recent Developments 73
10 Biologics and Biosimilars Market Forecast by Region 106
10.1 Global Biologics and Biosimilars Market Size Forecast 106
10.2 Global Biologics and Biosimilars Market Forecast by Region 106
10.2.1 North America Market Size Forecast by Country 107
10.2.2 Europe Biologics and Biosimilars Market Size Forecast by Country 108
10.2.3 Asia Pacific Biologics and Biosimilars Market Size Forecast by Region 108
10.2.4 South America Biologics and Biosimilars Market Size Forecast by Country 109
10.2.5 Middle East and Africa Forecasted Consumption of Biologics and Biosimilars by Country 109
11 Forecast Market by Type and by Application (2022-2028) 111
11.1 Global Biologics and Biosimilars Market Forecast by Type (2022-2028) 111
11.1.1 Global Forecasted Sales of Biologics and Biosimilars by Type (2022-2028) 111
11.1.2 Global Biologics and Biosimilars Market Size Forecast by Type (2022-2028) 111
11.1.3 Global Forecasted Price of Biologics and Biosimilars by Type (2022-2028) 112
11.2 Global Biologics and Biosimilars Market Forecast by Application (2022-2028) 112
11.2.1 Global Biologics and Biosimilars Sales (K Units) Forecast by Application 112
11.2.2 Global Biologics and Biosimilars Market Size (M USD) Forecast by Application (2022-2028) 113
12 Conclusion and Key Findings 114
List of Figures
?List of Tables
Table 1. Global Biologics and Biosimilars Sales (K Units) by Manufacturers (2017-2022) 1
Table 2. Global Biologics and Biosimilars Sales Market Share by Manufacturers (2017-2022) 2
Table 3. Global Biologics and Biosimilars Revenue (M USD) by Manufacturers (2017-2022) 3
Table 4. Global Biologics and Biosimilars Revenue Share by Manufacturers (2017-2022) 3
Table 5. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2020) 4
Table 6. Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers (2017-2022) 5
Table 7. Manufacturers Biologics and Biosimilars Sales Sites and Area Served 6
Table 8. Manufacturers Biologics and Biosimilars Product Type 6
Table 9. Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) 8
Table 10. Mergers & Acquisitions, Expansion Plans 9
Table 11. Industry Chain Map of Biologics and Biosimilars 10
Table 12. Raw Materials 10
Table 13. Midstream Market Analysis 11
Table 14. Downstream Customer Analysis 11
Table 15. Key Development Trends 13
Table 16. Driving Factors 13
Table 17. Biologics and Biosimilars Market Challenges 13
Table 18. Market Restraints 14
Table 19. Global Biologics and Biosimilars Sales by Type (K Units) 15
Table 20. Global Biologics and Biosimilars Market Size by Type (M USD) 16
Table 21. Global Biologics and Biosimilars Sales (K Units) by Type (2017-2022) 16
Table 22. Global Biologics and Biosimilars Sales Market Share by Type (2017-2022) 16
Table 23. Global Biologics and Biosimilars Market Size (M USD) by Type (2017-2022) 17
Table 24. Global Biologics and Biosimilars Market Size Share by Type (2017-2022) 17
Table 25. Global Biologics and Biosimilars Price (USD/Unit) by Type (2017-2022) 18
Table 26. Global Biologics and Biosimilars Sales (K Units) by Application 19
Table 27. Global Biologics and Biosimilars Market Size by Application 20
Table 28. Global Biologics and Biosimilars Sales by Application (2017-2022) & (K Units) 20
Table 29. Global Biologics and Biosimilars Sales Market Share by Application (2017-2022) 20
Table 30. Global Biologics and Biosimilars Sales by Application (2017-2022) & (M USD) 21
Table 31. Global Biologics and Biosimilars Market Share by Application (2017-2022) 21
Table 32. Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022) 22
Table 33. Global Biologics and Biosimilars Sales by Region (2017-2022) & (K Units) 23
Table 34. Global Biologics and Biosimilars Sales Market Share by Region (2017-2022) 23
Table 35. North America Biologics and Biosimilars Sales by Country (2017-2022) & (K Units) 24
Table 36. Europe Biologics and Biosimilars Sales by Country (2017-2022) & (K Units) 26
Table 37. Asia Pacific Biologics and Biosimilars Sales by Region (2017-2022) & (K Units) 27
Table 38. South America Biologics and Biosimilars Sales by Country (2017-2022) & (K Units) 29
Table 39. Middle East and Africa Biologics and Biosimilars Sales by Region (2017-2022) & (K Units) 30
Table 40. Roche Biologics and Biosimilars Basic Information 32
Table 41. Roche Biologics and Biosimilars Product Overview 32
Table 42. Roche Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 32
Table 43. Roche Business Overview 33
Table 44. Roche Biologics and Biosimilars SWOT Analysis 33
Table 45. Roche Recent Developments 33
Table 46. Amgen Biologics and Biosimilars Basic Information 34
Table 47. Amgen Biologics and Biosimilars Product Overview 34
Table 48. Amgen Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 34
Table 49. Amgen Business Overview 35
Table 50. Amgen Biologics and Biosimilars SWOT Analysis 35
Table 51. Amgen Recent Developments 35
Table 52. AbbVie Biologics and Biosimilars Basic Information 35
Table 53. AbbVie Biologics and Biosimilars Product Overview 36
Table 54. AbbVie Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 36
Table 55. AbbVie Business Overview 36
Table 56. AbbVie Biologics and Biosimilars SWOT Analysis 37
Table 57. AbbVie Recent Developments 37
Table 58. Sanofi-Aventis Biologics and Biosimilars Basic Information 37
Table 59. Sanofi-Aventis Biologics and Biosimilars Product Overview 38
Table 60. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 38
Table 61. Sanofi-Aventis Business Overview 38
Table 62. Sanofi-Aventis Biologics and Biosimilars SWOT Analysis 38
Table 63. Sanofi-Aventis Recent Developments 39
Table 64. Johnson & Johnson Biologics and Biosimilars Basic Information 39
Table 65. Johnson & Johnson Biologics and Biosimilars Product Overview 39
Table 66. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 40
Table 67. Johnson & Johnson Business Overview 40
Table 68. Johnson & Johnson Biologics and Biosimilars SWOT Analysis 40
Table 69. Johnson & Johnson Recent Developments 40
Table 70. Pfizer Biologics and Biosimilars Basic Information 41
Table 71. Pfizer Biologics and Biosimilars Product Overview 41
Table 72. Pfizer Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 41
Table 73. Pfizer Business Overview 42
Table 74. Pfizer Recent Developments 42
Table 75. Novo Nordisk Biologics and Biosimilars Basic Information 42
Table 76. Novo Nordisk Biologics and Biosimilars Product Overview 43
Table 77. Novo Nordisk Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 43
Table 78. Novo Nordisk Business Overview 43
Table 79. Novo Nordisk Recent Developments 43
Table 80. Eli Lilly Biologics and Biosimilars Basic Information 44
Table 81. Eli Lilly Biologics and Biosimilars Product Overview 44
Table 82. Eli Lilly Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 44
Table 83. Eli Lilly Business Overview 45
Table 84. Eli Lilly Recent Developments 45
Table 85. Novartis Biologics and Biosimilars Basic Information 45
Table 86. Novartis Biologics and Biosimilars Product Overview 46
Table 87. Novartis Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 46
Table 88. Novartis Business Overview 46
Table 89. Novartis Recent Developments 46
Table 90. Merck Biologics and Biosimilars Basic Information 47
Table 91. Merck Biologics and Biosimilars Product Overview 47
Table 92. Merck Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 47
Table 93. Merck Business Overview 48
Table 94. Merck Recent Developments 48
Table 95. 3sbio Biologics and Biosimilars Basic Information 48
Table 96. 3sbio Biologics and Biosimilars Product Overview 49
Table 97. 3sbio Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 49
Table 98. 3sbio Business Overview 49
Table 99. 3sbio Recent Developments 49
Table 100. Changchun High Tech Biologics and Biosimilars Basic Information 50
Table 101. Changchun High Tech Biologics and Biosimilars Product Overview 50
Table 102. Changchun High Tech Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 50
Table 103. Changchun High Tech Business Overview 51
Table 104. Changchun High Tech Recent Developments 51
Table 105. CP Guojian Biologics and Biosimilars Basic Information 51
Table 106. CP Guojian Biologics and Biosimilars Product Overview 52
Table 107. CP Guojian Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 52
Table 108. CP Guojian Business Overview 52
Table 109. CP Guojian Recent Developments 52
Table 110. Biotech Biologics and Biosimilars Basic Information 53
Table 111. Biotech Biologics and Biosimilars Product Overview 53
Table 112. Biotech Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 53
Table 113. Biotech Business Overview 54
Table 114. Biotech Recent Developments 54
Table 115. Gelgen Biologics and Biosimilars Basic Information 54
Table 116. Gelgen Biologics and Biosimilars Product Overview 55
Table 117. Gelgen Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin
(2017-2022) 55
Table 118. Gelgen Business Overview 55
Table 119. Gelgen Recent Developments 55
Table 120. Innovent Biologics and Biosimilars Basic Information 56
Table 121. Innovent Biologics and Biosimilars Product Overview 56
Table 122. Innovent Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 56
Table 123. Innovent Business Overview 57
Table 124. Innovent Recent Developments 57
Table 125. Dong Bao Biologics and Biosimilars Basic Information 57
Table 126. Dong Bao Biologics and Biosimilars Product Overview 58
Table 127. Dong Bao Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 58
Table 128. Dong Bao Business Overview 58
Table 129. Dong Bao Recent Developments 58
Table 130. Ganlee Biologics and Biosimilars Basic Information 59
Table 131. Ganlee Biologics and Biosimilars Product Overview 59
Table 132. Ganlee Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 59
Table 133. Ganlee Business Overview 60
Table 134. Ganlee Recent Developments 60
Table 135. United Laboratories Biologics and Biosimilars Basic Information 60
Table 136. United Laboratories Biologics and Biosimilars Product Overview 61
Table 137. United Laboratories Biologics and Biosimilars Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022) 61
Table 138. United Laboratories Business Overview 61
Table 139. United Laboratories Recent Developments 61
Table 140. Global Biologics and Biosimilars Sales Forecast by Region (K Units) 94
Table 141. Global Biologics and Biosimilars Market Size Forecast by Region (M USD) 95
Table 142. North America Biologics and Biosimilars Sales Forecast by Country (2022-2028) & (K Units) 95
Table 143. North America Biologics and Biosimilars Market Size Forecast by Country (2022-2028) & (M USD) 95
Table 144. Europe Biologics and Biosimilars Sales Forecast by Country (2022-2028) & (K Units) 96
Table 145. Europe Biologics and Biosimilars Market Size Forecast by Country (2022-2028) & (M USD) 96
Table 146. Asia Pacific Biologics and Biosimilars Sales Forecast by Region (2022-2028) & (K Units) 96
Table 147. Asia Pacific Biologics and Biosimilars Market Size Forecast by Region (2022-2028) & (M USD) 97
Table 148. South America Biologics and Biosimilars Sales Forecast by Country (2022-2028) & (K Units) 97
Table 149. South America Biologics and Biosimilars Market Size Forecast by Country (2022-2028) & (M USD) 97
Table 150. Middle East and Africa Biologics and Biosimilars Consumption Forecast by Country (2022-2028) & (Units) 97
Table 151. Middle East and Africa Biologics and Biosimilars Market Size Forecast by Country (2022-2028) & (M USD) 98
Table 152. Global Biologics and Biosimilars Sales Forecast by Type (2022-2028) & (K Units) 99
Table 153. Global Biologics and Biosimilars Market Size Forecast by Type (2022-2028) & (M USD) 99
Table 154. Global Biologics and Biosimilars Price Forecast by Type (2022-2028) & (USD/Unit) 100
Table 155. Global Biologics and Biosimilars Sales (K Units) Forecast by Application (2022-2028) 100
Table 156. Global Biologics and Biosimilars Market Size Forecast by Application (2022-2028) & (M USD) 101
List of Figures
Figure 1. Biologics and Biosimilars Sales Share by Manufacturers in 2020 2
Figure 2. Global Biologics and Biosimilars Revenue Share by Manufacturers in 2020 4
Figure 3. Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 5
Figure 4. Global Market Biologics and Biosimilars Average Price (USD/Unit) of Key Manufacturers in 2020 6
Figure 5. The Global 5 and 10 Largest Players: Market Share by Biologics and Biosimilars Revenue in 2020 9
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type) 15
Figure 7. Global Biologics and Biosimilars Market Share by Type 16
Figure 8. Sales Market Share of Biologics and Biosimilars by Type (2017-2022) 17
Figure 9. Sales Market Share of Biologics and Biosimilars by Type in 2020 17
Figure 10. Market Size Share of Biologics and Biosimilars by Type (2017-2022) 17
Figure 11. Market Size Market Share of Biologics and Biosimilars by Type in 2020 18
Figure 12. Global Biologics and Biosimilars Market Share by Application 20
Figure 13. Global Biologics and Biosimilars Sales Market Share by Application (2017-2022) 21
Figure 14. Global Biologics and Biosimilars Sales Market Share by Application in 2020 21
Figure 15. Global Biologics and Biosimilars Market Share by Application (2017-2022) 22
Figure 16. Global Biologics and Biosimilars Market Share by Application in 2020 22
Figure 17. Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022) 22
Figure 18. Global Biologics and Biosimilars Sales Market Share by Region (2017-2022) 23
Figure 19. North America Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 24
Figure 20. North America Biologics and Biosimilars Sales Market Share by Country in 2020 24
Figure 21. U.S. Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 25
Figure 22. Canada Biologics and Biosimilars Sales (K Units) and Growth Rate (2017-2022) 25
Figure 23. Mexico Biologics and Biosimilars Sales (Units) and Growth Rate (2017-2022) 25
Figure 24. Europe Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 25
Figure 25. Europe Biologics and Biosimilars Sales Market Share by Country in 2020 26
Figure 26. Germany Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 27. France Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 28. U.K. Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 26
Figure 29. Italy Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 27
Figure 30. Russia Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 27
Figure 31. Asia Pacific Biologics and Biosimilars Sales and Growth Rate (K Units) 27
Figure 32. Asia Pacific Biologics and Biosimilars Sales Market Share by Region in 2020 27
Figure 33. China Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 34. Japan Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 35. South Korea Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 36. India Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 37. Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 28
Figure 38. South America Biologics and Biosimilars Sales and Growth Rate (K Units) 28
Figure 39. South America Biologics and Biosimilars Sales Market Share by Country in 2020 29
Figure 40. Brazil Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 41. Argentina Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 42. Columbia Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 29
Figure 43. Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (K Units) 29
Figure 44. Middle East and Africa Biologics and Biosimilars Sales Market Share by Region in 2020 30
Figure 45. Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 46. UAE Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 47. Egypt Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 30
Figure 48. Nigeria Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 31
Figure 49. South Africa Biologics and Biosimilars Sales and Growth Rate (2017-2022) & (K Units) 31
Figure 50. Global Biologics and Biosimilars Sales Forecast by Volume (2017-2028) & (K Units) 94
Figure 51. Global Biologics and Biosimilars Market Size Forecast by Value (2017-2028) & (M USD) 94
Figure 52. Global Biologics and Biosimilars Sales Market Share Forecast by Type (2022-2028) 99
Figure 53. Global Biologics and Biosimilars Market Share Forecast by Type (2022-2028) 99
Figure 54. Global Biologics and Biosimilars Sales Forecast by Application (2022-2028) 100
Figure 55. Global Biologics and Biosimilars Market Share Forecast by Application (2022-2028) 101
US $
Euro €
GBP £
